Read the findings from the ANCHOR randomized controlled trial, evaluating the efficacy and safety of combination therapy with entecavir, peginterferon alfa-2b, and GM-CSF. This important study provides robust clinical evidence on combination treatment strategies aimed at improving outcomes in chronic hepatitis B management.